Core Insights - The Pennant Group is optimistic about business momentum and growth initiatives while emphasizing a cautious approach to integrating major acquisitions and navigating a changing competitive landscape [6] Acquisition and Integration - The integration of the newly acquired operations from UnitedHealth Group and Amedisys is structured into five waves, with the second wave currently being completed and the full transition expected to conclude by the end of October [7] - Management is taking a methodical approach to integration to reduce risk and retain strong teams, acknowledging that the current integration is more complex than previous acquisitions [1][4] - Early feedback from employees has been positive, with a strong commitment to the company's culture and clarity about the transition [8] Financial Guidance and Performance - The company’s guidance includes conservatism due to the scale and complexity of the recent transactions, with expectations for margin expansion in both Home Health and Hospice segments [2][12] - For 2026, the company anticipates an annualized margin close to 10.5% for the acquired business, with a long-term goal of reaching an 18% target margin [10][11] - The company expects an annualized EBITDA margin around 16% for Home Health and Hospice, and around 11% for Senior Living [12] Market Dynamics and Opportunities - The competitive landscape has shifted, with large players entering integration cycles, creating increased opportunities for Pennant [13] - The company has expanded its footprint into the Southeast and Northeast, enhancing its national profile and payer negotiations [14] - There are numerous attractive acquisition opportunities available, although the company is focusing on tuck-in deals due to the integration workload [15] Senior Living and Regulatory Environment - In Senior Living, occupancy has improved, with a current rate of around 81% and a goal of 85% [16] - The company expressed gratitude for a reduced home health rate adjustment, which alleviates some regulatory pressure [17] Strategic Focus - The company emphasizes local leadership and organic growth alongside acquisitions, with technology and AI investments seen as key strategic focuses for future value creation [18]

Financial Data and Key Metrics Changes - The company reported full-year consolidated revenue of $947.7 million, an increase of $252.5 million, or 36.3% year-over-year [8] - Adjusted EBITDA for the full year was $72.5 million, up $19.2 million, or 36% [8] - Adjusted earnings per share for the full year reached $1.18, exceeding the midpoint of the updated annual guidance of $1.16 [7] Business Line Data and Key Metrics Changes - In the home health and hospice segment, Q4 revenue was $233.3 million, an increase of $91.3 million, or 64.3% year-over-year [14] - Adjusted EBITDA for the home health segment in Q4 was $33.7 million, up $12.4 million, or 58.2% [14] - The senior living segment saw full-year revenue improve to $215 million, an increase of $39.2 million, or 22.3% [17] Market Data and Key Metrics Changes - The average daily census in the hospice segment grew to 5,060, a 46.9% increase over the prior year quarter [16] - Same-store Medicare admissions in home health grew by 8.2%, with a 3.7% increase in Medicare revenue per episode [15] - All-store occupancy in the senior living segment rose to 80.6%, with same-store occupancy increasing to 82.1% [18] Company Strategy and Development Direction - The company is focused on optimizing performance and driving operational excellence while remaining open to selective acquisitions [10] - Key focus areas include leadership development, clinical excellence, employee experience, margin improvement, and growth [9] - The company plans to continue expanding its senior living business, with significant growth potential identified [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying trajectory of the business despite reimbursement headwinds [15] - The company anticipates a full-year revenue guidance for 2026 in the range of $1.13 billion to $1.17 billion, reflecting a 22.4% increase at the midpoint [12] - Management highlighted the importance of local leadership in driving growth and maintaining strong clinical outcomes [59] Other Important Information - The company completed two senior living acquisitions in Q4, reinforcing its strategic commitment to expanding high-quality senior care [21][22] - The balance sheet remains strong, with a net debt to adjusted EBITDA ratio of 1.7 times, well under the covenant limit [24] Q&A Session Summary Question: Is the guidance conservative due to the Amedisys/LHCG integration? - Management confirmed that the guidance reflects a conservative approach due to expected initial noise during the transition [32] Question: How do joint ventures perform compared to non-JV agencies? - Management stated that joint ventures are treated like any Pennant business, focusing on local leadership and collaboration with health system partners [34] Question: What are the expectations for the Amedisys UNH asset ramp-up compared to Signature? - Management noted similarities in leadership quality and operational readiness, expressing confidence in the transition process [41] Question: What is the expected same-store revenue growth for 2026? - Management indicated a projected 7% increase in home health and hospice revenue for 2026 [53] Question: What is the competitive backdrop in the hospice segment? - Management highlighted a normalization in growth trends and emphasized the opportunity presented by the aging population [80]

Financial Data and Key Metrics Changes - The company reported full-year consolidated revenue of $947.7 million, an increase of $252.5 million, or 36.3% year-over-year [8] - Adjusted EBITDA for the full year was $72.5 million, up $19.2 million, or 36% compared to the previous year [8] - Adjusted earnings per share for the full year reached $1.18, exceeding the midpoint of the updated annual guidance of $1.16 [7][8] Business Line Data and Key Metrics Changes - In the home health and hospice segment, Q4 revenue was $233.3 million, an increase of $91.3 million, or 64.3% year-over-year, with adjusted EBITDA of $33.7 million, up $12.4 million, or 58.2% [14] - The senior living segment saw full-year revenue improve to $215 million, an increase of $39.2 million, or 22.3% over the prior year [17] - Q4 senior living segment revenue was $56.1 million, an increase of $9.2 million, or 19.6% year-over-year [17] Market Data and Key Metrics Changes - The average daily census in hospice grew to 5,060, a 46.9% increase over the prior year quarter [16] - Same-store Medicare admissions in home health grew by 8.2%, with a 3.7% increase in Medicare revenue per episode [15] - All-store occupancy in senior living rose by 200 basis points to 80.6%, with same-store occupancy increasing by 250 basis points to 82.1% [18] Company Strategy and Development Direction - The company aims to optimize performance and drive operational excellence while remaining open to selective acquisitions [10] - Focus areas include leadership development, clinical excellence, employee experience, margin improvement, and growth [9] - The company plans to continue expanding its senior living business, capitalizing on the upward trajectory of occupancy and revenue [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying trajectory of the business despite reimbursement headwinds [15] - The company anticipates a full-year revenue guidance of $1.13 billion to $1.17 billion for 2026, reflecting a 22.4% increase at the midpoint [12] - Management highlighted the importance of local leadership and community engagement in driving growth and clinical outcomes [59] Other Important Information - The company completed the acquisition of Signature Healthcare at Home and over 50 locations from UnitedHealth and Amedisys, enhancing its operational reach [8][9] - The balance sheet remains strong, with a net debt to adjusted EBITDA ratio of 1.7 times, well below the covenant limit [24] Q&A Session Summary Question: Is the guidance conservative due to the integration of AMED LHCG? - Management confirmed that the guidance reflects expected initial noise during the transition of operations [32] Question: How do joint ventures perform compared to non-JV agencies? - Management stated that joint ventures are treated like any Pennant business, focusing on local leadership and collaboration with health system partners [34] Question: What are the expectations for the ramp-up of Amedisys UNH assets? - Management noted similarities with previous acquisitions and expressed confidence in local leaders and teams to facilitate a smooth transition [41][42] Question: What is the outlook for same-store revenue growth in home health and hospice? - Management indicated a projected 7% increase in same-store home health and hospice revenue for 2026 [53] Question: What is the competitive backdrop in the hospice segment? - Management highlighted a normalization in growth trends and the opportunity presented by the aging population [80]

Financial Data and Key Metrics Changes - The company reported full-year consolidated revenue of $947.7 million, an increase of $252.5 million, or 36.3% year-over-year [6] - Adjusted EBITDA for the full year was $72.5 million, up $19.2 million, or 36% compared to the previous year [6] - Adjusted earnings per share for the full year reached $1.18, exceeding the midpoint of the updated annual guidance of $1.16 [5][6] Business Line Data and Key Metrics Changes - In the home health and hospice segment, Q4 revenue was $233.3 million, an increase of $91.3 million, or 64.3% year-over-year, with adjusted EBITDA of $33.7 million, up $12.4 million, or 58.2% [12] - Fourth quarter admissions surged 81.3%, with Medicare admissions growing 87.5% year-over-year [12] - The senior living segment saw full-year revenue improve to $215 million, an increase of $39.2 million, or 22.3% over the prior year [16] Market Data and Key Metrics Changes - The average daily census in hospice care grew to 5,060, a 46.9% increase over the prior year quarter [15] - Same-store Medicare admissions in home health grew 8.2%, with a 3.7% increase in Medicare revenue per episode [13] - All store occupancy in senior living rose 200 basis points to 80.6%, with same-store occupancy ending the year at 82.1% [17] Company Strategy and Development Direction - The company is focused on optimizing performance and driving operational excellence while remaining open to selective acquisitions [9] - Key focus areas include leadership development, clinical excellence, employee experience, margin improvement, and growth [8] - The company aims to continue the upward trajectory of its senior living business, with significant growth potential ahead [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying trajectory of the business despite reimbursement headwinds [15] - The company anticipates a full-year revenue guidance of $1.13 billion to $1.17 billion for 2026, reflecting a 22.4% increase at the midpoint [11] - Management highlighted the importance of local leadership in responding to community needs and driving organic growth [57] Other Important Information - The company completed significant acquisitions, including the purchase of over 50 locations from UnitedHealth and Amedisys, enhancing its reach in the Southeast [8] - The balance sheet remains strong, with a net debt to adjusted EBITDA ratio of 1.7 times, well under the covenant limit [23] - The company generated $21 million of cash flows from operations in Q4, bringing the year-to-date total to $48.3 million [23] Q&A Session Summary Question: Is the guidance conservative due to the integration of Amedisys and UnitedHealth? - Management confirmed that the guidance reflects a conservative approach due to expected initial noise during the transition of operations [30] Question: How do joint ventures perform compared to non-JV agencies? - Management stated that joint ventures are treated like any Pennant business, focusing on local leadership and collaboration with health system partners to achieve exceptional outcomes [32] Question: How does the Amedisys and UnitedHealth asset ramp-up compare to Signature? - Management noted similarities in leadership quality and operational strengths, expressing confidence in the transition process based on past experiences [39] Question: What is the expected same-store revenue growth for 2026? - Management indicated a projected 7% increase in home health and hospice revenue for 2026, despite anticipated rate decreases [51] Question: What is the competitive landscape in the hospice segment? - Management highlighted a normalization in growth rates post-pandemic, with strong organic growth driven by local community needs [78]

Core Viewpoint - The Pennant Group, Inc. is set to release its fourth quarter and fiscal year 2025 financial results on February 25, 2026, followed by a live webcast on February 26, 2026, where management will discuss these results [1][2]. Group 1: Financial Results Announcement - The Pennant Group, Inc. will issue its financial results for the fourth quarter and fiscal year 2025 on February 25, 2026 [1]. - A live webcast is scheduled for February 26, 2026, at 10:00 a.m. Mountain Time to discuss the financial results [2]. Group 2: Company Overview - The Pennant Group, Inc. operates as a holding company for independent subsidiaries providing healthcare services, including home health, hospice, and senior living in 17 states [4]. - Each subsidiary operates independently with its own management, employees, and assets, indicating a decentralized operational structure [4].

Core Insights - The session is part of a virtual home care conference hosted by BofA Securities, featuring Enhabit, a major player in the home health and hospice sector in the U.S. [2] Company Overview - Enhabit is recognized as one of the largest home health and hospice providers in the United States [2]. Leadership - The session includes insights from Barb Jacobsmeyer, the President and CEO of Enhabit, and Ryan Solomon, the CFO [2]. Audience Engagement - The audience is encouraged to participate by submitting questions through a designated window during the Q&A session [3].

Summary of The Pennant Group FY Conference Call Company Overview - **Company**: The Pennant Group (NasdaqGS:PNTG) - **Industry**: Home health and hospice services, senior living facilities Key Points and Arguments 1. Growth and Acquisitions - The Pennant Group had a productive year in 2025, starting with the second tranche of the Signature acquisition and culminating in the purchase of a large portfolio from UnitedHealth and Amedisys [25][26] - The company emphasizes investment in leadership, which has led to organic growth in operations, surpassing previous performance levels [27][28] 2. Integration Process - The integration of new acquisitions involves a structured approach focusing on leadership readiness, operational health, and the opportunity presented by the acquisition [31][32] - A typical optimization process post-acquisition spans about nine quarters, involving technology integration and rebranding efforts [33][34] 3. Financial Management - The company expects G&A costs to normalize from approximately 6.7% to 6.5% by the end of 2026, despite initial increases due to acquisitions [36][37] - Current leverage is around two times net debt to adjusted EBITDA, with a comfortable range of two to two and a half times for future acquisitions [39][40] 4. Referral Dynamics and Partnerships - The partnership with Ensign has provided operational benefits, including shared expertise and clinical collaboration, although referrals from Ensign's skilled nursing operations remain low [46][47] - The company is exploring joint venture opportunities with health systems to enhance care delivery and improve clinical outcomes [66][67] 5. Reimbursement and Quality Measures - The Pennant Group has achieved a 4.1 CMS Star Rating, which has helped reduce the differential between Medicare Advantage (MA) rates and fee-for-service rates to 20-25% [58][59] - The company is focused on driving down costs while maintaining quality, which is crucial for negotiations with payers [61][62] 6. Hospice Operations - The company sees potential for growth in hospice length of stay, currently just under 100 days, with a target to improve without exceeding caps [76][77] - The hospice segment is expected to grow in the mid to high single digits, with a focus on maintaining quality care [78][79] 7. Senior Living Performance - The senior living segment has seen high occupancy rates and successful rate increases, attributed to capital investments and improved service offerings [88][89] - The company aims to increase the proportion of healthcare services provided, currently at 20-25%, with a long-term goal of 25-33% [91][92] 8. Labor and Staffing - The company has made significant improvements in caregiver onboarding and retention, leading to decreased turnover and enhanced employee experience [94] - Current staffing levels are sufficient to support increased occupancy, with ongoing efforts to scale as demand grows [94] 9. Future Outlook - The Pennant Group is targeting a 15% margin in senior living, with expectations that increased occupancy and operational efficiencies will contribute to this goal [96][97] Additional Important Insights - The company is actively involved in discussions with CMS regarding reimbursement methodologies, emphasizing the importance of home health services in the continuum of care [71][72] - The focus on leadership development and creating opportunities for local leaders is a core part of the company's strategy, differentiating it in a fragmented market [50][54]

Core Insights - The company has seen success in its strategies implemented over the past few years, particularly in hospice care, which continues to outperform expectations [1] - The payer strategy in home health is beginning to yield positive results, especially in negotiations with various payers [1] - The company has focused on reducing leverage, which has contributed to improved free cash flow [1] - Overall performance for 2025 is viewed positively, with a strong start to the fourth quarter [1]

Group 1 - The Pennant Group, Inc. will participate in the 2025 Stephens Annual Investment Conference on November 19, 2025 [1] - Key executives including the CFO, COO, and President of the Senior Living segment will engage in a fireside chat during the conference [2] - A live webcast of the event will be available for interested parties [2] Group 2 - The Pennant Group operates 141 home health and hospice agencies and 61 senior living communities across multiple states in the U.S. [3] - Each operating subsidiary within the Pennant Group functions independently with its own management and assets [3] - The company emphasizes that it does not directly operate the individual businesses under its umbrella [3]

Group 1 - Enhabit, Inc. is a leading national home health and hospice provider [1] - The company will participate in the Jefferies 2025 Healthcare Services Conference [1] - Enhabit's President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will engage in a fireside chat on September 30 at 10:55 a.m. CT [1] Group 2 - The fireside chat will be webcast live and available for replay on Enhabit's investor website [1]